(VIANEWS) – Trip.com (TCOM), Ares Management L.P. (ARES), Gentex Corporation (GNTX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Trip.com (TCOM)
97.5% sales growth and 5.55% return on equity
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Trip.com has a trailing twelve months EPS of $1.3.
PE Ratio
Trip.com has a trailing twelve months price to earnings ratio of 26.84. Meaning, the purchaser of the share is investing $26.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.55%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 180.4%, now sitting on 32.36B for the twelve trailing months.
Moving Average
Trip.com’s worth is under its 50-day moving average of $38.03 and under its 200-day moving average of $36.40.
Yearly Top and Bottom Value
Trip.com’s stock is valued at $34.90 at 01:22 EST, way under its 52-week high of $43.59 and way higher than its 52-week low of $19.25.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 191.3% and 145.5%, respectively.
2. Ares Management L.P. (ARES)
16.2% sales growth and 16.04% return on equity
Ares Management Corporation operates as an alternative asset manager in the United States, Europe, and Asia. The company's Tradable Credit Group segment manages various types of investment funds, such as commingled and separately managed accounts for institutional investors, and publicly traded vehicles and sub-advised funds for retail investors in the tradable and non-investment grade corporate credit markets. Its Direct Lending Group segment provides financing solutions to small-to-medium sized companies. The company's Private Equity Group segment focuses on majority or shared-control investments primarily in under-capitalized companies. Its Real Estate Group segment invests in new developments and the repositioning of assets, with a focus on control or majority-control investments; and originates and invests in a range of self-originated financing opportunities for middle-market owners and operators of commercial real estate. The firm was previously known as Ares Management, L.P. Ares Management Corporation was founded in 1997 and is headquartered in Los Angeles, California with additional offices in the United States, Europe and Asia. Ares Management GP LLC is the general partner of the company.
Earnings Per Share
As for profitability, Ares Management L.P. has a trailing twelve months EPS of $1.66.
PE Ratio
Ares Management L.P. has a trailing twelve months price to earnings ratio of 64.01. Meaning, the purchaser of the share is investing $64.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.04%.
Yearly Top and Bottom Value
Ares Management L.P.’s stock is valued at $106.26 at 01:22 EST, below its 52-week high of $107.37 and way higher than its 52-week low of $58.60.
Moving Average
Ares Management L.P.’s worth is above its 50-day moving average of $101.22 and way above its 200-day moving average of $86.48.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Sep 13, 2023, the estimated forward annual dividend rate is 2.92 and the estimated forward annual dividend yield is 2.79%.
3. Gentex Corporation (GNTX)
14% sales growth and 17.48% return on equity
Gentex Corporation designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection products in the United States, Germany, Japan, Mexico, and internationally. It operates through Automotive Products and Other segments. The company offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and non-automatic-dimming rearview mirrors for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, automotive suppliers, and various aftermarket and accessory customers. It also provides variable dimmable windows to aircraft manufacturers and airline operators. In addition, the company offers photoelectric smoke detectors and alarms, electrochemical carbon monoxide alarms and detectors, audible and visual signaling alarms, and bells and speakers used in fire detection systems in office buildings, hotels, and other commercial and residential buildings, as well as researches and develops nanofiber chemical sensing products. The company sells its fire protection products directly, as well as through sales managers and manufacturer representative organizations to fire protection and security product distributors, electrical wholesale houses, and original equipment manufacturers of fire protection systems. Gentex Corporation was incorporated in 1974 and is headquartered in Zeeland, Michigan.
Earnings Per Share
As for profitability, Gentex Corporation has a trailing twelve months EPS of $1.56.
PE Ratio
Gentex Corporation has a trailing twelve months price to earnings ratio of 20.36. Meaning, the purchaser of the share is investing $20.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.48%.
Moving Average
Gentex Corporation’s value is under its 50-day moving average of $32.45 and above its 200-day moving average of $29.09.
Previous days news about Gentex Corporation(GNTX)
- According to Zacks on Monday, 2 October, "Other major players are Corning Incorporated (GLW Quick QuoteGLW – Free Report) and Gentex Corporation (GNTX Quick QuoteGNTX – Free Report) . "
4. American Express (AXP)
13.1% sales growth and 29.8% return on equity
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, American Express has a trailing twelve months EPS of $9.85.
PE Ratio
American Express has a trailing twelve months price to earnings ratio of 15.16. Meaning, the purchaser of the share is investing $15.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.8%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 19.8% and 37.7%, respectively.
Previous days news about American Express(AXP)
- According to Zacks on Monday, 2 October, "There are other competitors in the payments space providing digital banking products and credit payment services, including American Express Company (AXP Quick QuoteAXP – Free Report) and Discover Financial Services (DFS Quick QuoteDFS – Free Report) , with comparatively lower market share. "
5. Vertex Pharmaceuticals (VRTX)
9.3% sales growth and 24.56% return on equity
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO and SYMDEKO/SYMKEVI for people with CF with at least one F508del mutation for 6 years of age or older; ORKAMBI for CF homozygous F508del mutation for CF patients 2 year or older; and KALYDECO for the treatment of patients with 4 months or older who have CF with a mutation that is responsive to ivacaftor, and R117H mutation or one of certain gating mutations. The company's pipeline includes VX-522, a CF mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial; and VX-864 for treatment of AAT deficiency, which is in Phase 2 clinical trial. In addition, it provides VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sell the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies or pharmacy chains, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Affinia Therapeutics; Arbor Biotechnologies, Inc.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Obsidian Therapeutics, Inc.; Verve Therapeutics; Skyhawk Therapeutics; and Ribometrix, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $13.04.
PE Ratio
Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 26.43. Meaning, the purchaser of the share is investing $26.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.56%.
Sales Growth
Vertex Pharmaceuticals’s sales growth is 12.1% for the ongoing quarter and 9.3% for the next.
Previous days news about Vertex Pharmaceuticals(VRTX)
- According to Zacks on Monday, 2 October, "Last month, Vertex Pharmaceuticals reported its second-quarter 2023 results, wherein it recorded a robust uptick in product revenues. "
6. HireQuest (HQI)
7.7% sales growth and 19.41% return on equity
HireQuest, Inc. provides on-demand and temporary staffing solutions in the United States. The company provides temporary staffing services, including skilled and semi-skilled labor and industrial personnel, clerical and administrative personnel, and construction personnel. As of March 25, 2021, the company had a network of approximately 139 franchisee-owned offices in 35 states and the District of Columbia. It serves customers primarily in the construction, industrial/manufacturing, warehousing, hospitality, recycling/waste management, disaster recovery, logistics, auctioneering, landscaping, and retail industries. The company was formerly known as Command Center, Inc. and changed its name to HireQuest, Inc. in September 2019. HireQuest, Inc. was founded in 2002 and is headquartered in Goose Creek, South Carolina.
Earnings Per Share
As for profitability, HireQuest has a trailing twelve months EPS of $0.8.
PE Ratio
HireQuest has a trailing twelve months price to earnings ratio of 21.01. Meaning, the purchaser of the share is investing $21.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.41%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 34.76M for the twelve trailing months.
7. Allegion plc Ordinary Shares (ALLE)
5.1% sales growth and 53.7% return on equity
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers and controls; doors and door systems; electronic security products; electronic, biometric and mobile access control systems; exit devices; locks, locksets, portable locks, and key systems; time, attendance, and workforce productivity systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facilities, including education, healthcare, government, hospitality, commercial office, and single and multi-family residential markets under the CISA, Interflex, LCN, Schlage, SimonsVoss, and Von Duprin brands. It sells its products and solutions through distribution and retail channels, such as specialty distribution, e-commerce, and wholesalers, as well as through various retail channels comprising do-it-yourself home improvement centers, on-line and e-commerce platforms, and small specialty showroom outlets. Allegion plc was incorporated in 2013 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Allegion plc Ordinary Shares has a trailing twelve months EPS of $5.85.
PE Ratio
Allegion plc Ordinary Shares has a trailing twelve months price to earnings ratio of 17.9. Meaning, the purchaser of the share is investing $17.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.7%.
Moving Average
Allegion plc Ordinary Shares’s value is below its 50-day moving average of $113.54 and below its 200-day moving average of $111.28.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 5.5% and 5.6%, respectively.
